 HAIFA, Israel, Oct. 31, 2022 GLOBE NEWSWIRE -- Pluri Inc. Nasdaq: PLUR TASE: PLUR Pluri or the Companyformerly known as Pluristem Therapeutics, Inc., a leading biotechnology company, today announced its participation in three upcoming conferences. 